Every 10-Q that VISTEON CORPORATION (VC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow VC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VC filings page.
Visteon Corporation reported softer profitability for the quarter and six months ended June 30, 2026. Quarterly net sales were $960 million, slightly below 2025, while net income attributable to Visteon declined to $49 million and diluted EPS to $1.80 as higher engineering costs, unfavorable currency and semiconductor-related cost pressures compressed gross margin from $141 million to $118 million.
For the first half of 2026, net sales were $1.914 billion, but net income attributable to Visteon fell to $80 million and Adjusted EBITDA to $220 million from $263 million, reflecting increased restructuring expense of $17 million, higher warranty and semiconductor costs, and adverse foreign exchange. Operating cash flow decreased to $43 million versus $165 million a year earlier.
Liquidity remained solid with $648 million of cash and equivalents and term debt of $284 million. The company amended its credit agreement to extend maturity to 2031, completed a $24 million software acquisition adding safety-focused capabilities, and intensified restructuring efforts while continuing shareholder returns through a $0.375 quarterly dividend, $36 million of buybacks year-to-date, a new $800 million repurchase authorization, and a $200 million accelerated share repurchase launched in July 2026.
Visteon Corporation reported Q1 2026 net income attributable to Visteon of $31 million, down from $67 million a year earlier. Net sales edged up to $954 million from $934 million, but gross margin fell to $113 million from $138 million as higher costs and unfavorable items offset growth.
Adjusted EBITDA declined to $104 million from $129 million, reflecting lower volume, annual customer price reductions, higher engineering and semiconductor costs, and currency headwinds. Operating cash flow dropped to $6 million from $70 million, affected by working capital outflows, while cash and equivalents remained strong at $682 million.
The company recorded $18 million of restructuring expense tied to headcount actions and footprint optimization and ended the quarter with restructuring reserves of $33 million. Visteon continued its capital return strategy, repurchasing 329,530 shares for $30 million and paying a quarterly dividend of $0.375 per share, or $10 million in total, while maintaining $400 million of unused revolver capacity and term debt of $297 million.
Visteon Corporation filed an amended quarterly report to revise Item 5 and add an omitted disclosure about Rule 10b5-1 trading plans adopted during the quarter ended September 30, 2025. The company also filed new CEO and CFO certifications as exhibits; no financial statements were included and other disclosures were not updated.
Plans disclosed: CEO Sachin S. Lawande’s plan provides for the exercise and sale of up to 99,874 stock options; CFO Jerome Rouquet’s plan provides for the sale of 9,392 shares and the exercise and sale of up to 4,675 shares; SVP Qais Sharif adopted a plan covering 2,200 shares. Shares outstanding were 27,285,922 as of October 16, 2025.
Visteon Corporation reported Q3 2025 results showing lower revenue but stronger profitability. Net sales were $917 million versus $980 million a year ago, while gross margin held at $131 million. Net income attributable to Visteon rose to $57 million from $39 million, and diluted EPS increased to $2.04 from $1.40. The quarter benefited from cost performance and lower restructuring, partly offset by higher net engineering spend and customer pricing pressure.
Year to date, net sales were $2.82 billion versus $2.93 billion in 2024, with net income attributable to Visteon at $187 million (up from $152 million). Operating cash flow reached $292 million for the nine months, lifting cash and equivalents to $762 million at September 30, 2025. The company closed a $55 million UX-focused acquisition (up to $9 million contingent), continued modest buybacks, and paid a $0.275 dividend per share. Term debt stood at $288 million with no revolver borrowings. Subsequent to quarter end, a supplier reported Chinese export controls on certain components; Visteon is pursuing mitigations, with potential impact uncertain.